Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00277-014-2295-6.pdf
Reference34 articles.
1. Dohner H, Estey EH, Amadori S et al (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115:453–474
2. Slovak ML, Kopecky KJ, Cassileth PA et al (2000) Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 96:4075–4083
3. Chung SS (2014) Genetic mutations in acute myeloid leukemia that influence clinical decisions. Curr Opin Hematol 21:87–94
4. Lin TL, Smith BD (2011) Prognostically important molecular markers in cytogenetically normal acute myeloid leukemia. Am J Med Sci 341:404–408
5. Bergmann L, Miething C, Maurer U et al (1997) High levels of Wilms’ tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 90:1217–1225
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Expression of Wilms tumor one gene, cyclin D1, and p53 in acute leukemia – An immunohistochemical study in a tertiary care center from North India;Journal of Hematology and Allied Sciences;2024-06-20
2. Clinical characteristics and prognostic factors analysis of core binding factor acute myeloid leukemia in real world;Cancer Medicine;2023-12
3. Prognostic value of the WT-1 gene combined with recurrent cytogenetic genes in acute myeloid leukemia;Immunogenetics;2023-06-22
4. Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B‐cell lymphoma;Hematological Oncology;2023-06-08
5. High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk;Clinical and Experimental Medicine;2023-01-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3